Related Experiment Videos
A review of osteoinductive testing methods and sterilization processes for demineralized bone
1Department of Orthopedic Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. jglowacki@partners.org
Cell and Tissue Banking
|March 1, 2005
Summary
Allogeneic demineralized bone is a common bone graft material. Current testing methods do not reliably predict clinical performance, necessitating further research and clinical monitoring for product release.
Area of Science:
- Biomaterials Science
- Orthopedic Surgery
- Tissue Engineering
Background:
- Allogeneic demineralized bone is widely used clinically for its osteoinductive and osteoconductive properties.
- Concerns exist regarding processing and sterilization potentially impacting the efficacy of demineralized bone allografts.
- Clinicians require assurances of product potency and consistent clinical performance.
Purpose of the Study:
- To evaluate the current knowledge on the performance of allogeneic demineralized bone.
- To determine if in vitro and in vivo testing can predict clinical outcomes.
- To assess the feasibility of establishing release standards for demineralized bone allografts.
Main Methods:
- Review of existing literature on demineralized bone allograft performance.
- Analysis of data from animal and cell culture models.
- Evaluation of the correlation between laboratory tests and clinical results.
Main Results:
- Extensive data exists from animal and cell culture models for demineralized bone.
- Current in vivo and in vitro test systems cannot reliably predict the clinical performance of different demineralized bone allograft lots.
- The development of evidence-based standards for product release is challenging.
Conclusions:
- The clinical performance of demineralized bone allografts cannot be reliably concluded from current in vitro or in vivo testing.
- An osteoinductivity standard for market release may be feasible but requires subsequent clinical monitoring.
- Further research is essential to establish reliable predictors of clinical efficacy for demineralized bone allografts.